期刊文献+

234853名无偿献血公民的血液传染病标志物检测结果分析 被引量:1

下载PDF
导出
摘要 目的了解无偿献血公民身体健康状况,屏蔽不合格献血公民,确保受血者安全,避免因输血感染血源性传染病而引起的医疗纠纷。方法酶联免疫吸附试验检测血液传染病标志物乙型肝炎表面抗原(HBsAg)、丙型肝炎病毒抗体(抗-HCV)、人类免疫缺陷病毒抗体(抗-HIV)和梅毒抗体(抗-TP),两个不同厂家的检测试剂进行平行双检,对检测结果进行分类统计及分析。结果在234 853例献血公民中,HBsAg阳性率为5.85‰(1 375例),抗-HCV阳性率为2.67‰(628例),抗-HIV阳性率为0.07‰(17例),抗-TP阳性率为4.43‰(1 041例)。不同年度间的HBsAg和抗-HCV的阳性率尽管有差异,但差异无统计学意义(P>0.05),而抗-HIV和抗-TP阳性率却呈逐年上升趋势,差异有统计学意义(P<0.05)。结论部分无偿献血公民携带血源性传染病毒,血站应不断加强无偿献血公民血源性传染病标志物的检测质量,最大限度地减少因输血而感染传染病的案例数。
作者 杨爱龙 周川
出处 《检验医学与临床》 CAS 2012年第7期824-825,共2页 Laboratory Medicine and Clinic
  • 相关文献

参考文献6

二级参考文献18

共引文献39

同被引文献35

  • 1Ludwig H, Van Belle S, Barrett-Lee P, et al. The European Cancer Anaemia Survey (ECAS) : a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer, 2004, 40(15) :2293-2306.
  • 2Birgegrd G, Aapro MS, Bokemeyer C, et al. Cancer-related anemia: pathogenesis, prevalence and treatment. Oncology, 2005, 68 Suppl 1:3-11.
  • 3Crawford J. Anemia and lung cancer. Lung Cancer, 2002, 38 Suppl 3 : $75-78.
  • 4Yu Y, Xu X, Du Z, et al. Non-platinum regimens of gemcitabine plus docetaxel versus platinum-based regimens in first-line treatment of advanced non-small cell lung cancer: a meta-analysis on 9 randomized controlled trials. Cancer Chemother Pharmacol, 2012, 69(5 ) : 1265- 1275.
  • 5Amarasena IU, Waiters JA, Wood-Baker R, et al. Platinum versus non-platinum chemotherapy regimens for small cell lung cancer. Cochrane Database Syst Rev, 2008, (4) :CD006849.
  • 6Celia D. Factors influencing quality of life in cancer patients : anemia and fatigue. Semin Oncol, 1998, 25 (3 Suppl 7) :43-46.
  • 7Curt GA. Impact of fatigue on quality of life in oncology patients. Semin Hematol, 2000, 37 (4 Suppl 6) :14-17.
  • 8Sloan JA, Zhao X, Novotny PJ, et al. Relationship between deficits in overall quality of life and non-small-cell lung cancer survival. J Clin Oneol, 2012, 30( 13 ) : 1498-1504.
  • 9Caro JJ, Salas M, Ward A, et al. Anemia as an independent prog- nostic factor for survival in patients with cancer: a systemic, quanti- tative review. Cancer, 2001,91 (12) :2214-2221.
  • 10Aoe K, Hiraki A, Maeda T, et al. Serum hemoglobin level deter- mined at the first presentation is a poor prognostic indicator in patients with lung cancer. Intern Med, 2005, 44 ( 8 ) : 800-804.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部